The question of whether Ozempic can be safely used in patients with Crohn's disease requires careful consideration, as there is no official contraindication listed in the Summary of Product Characteristics (SmPC) specifically for inflammatory bowel disease
With our support, this time will be different
A total of 17,061 patients completed the trial, with a mean follow-up period of 39.8 9.4 months
A modest decline is expected during calorie restriction
GLP-1 weight loss consulting offers a clinically proven approach to medical weight management by combining FDA-approved prescription medications with expert medical oversight
PlexusDx offers compounded semaglutide injection at $189/mo month-to-month, or from $149/mo on the 6-month plan, allowing patients to restart or maintain therapy without the disruption of stopping entirely